EIM
NEOS

Essex Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Essex Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-285,716
Closed -$1.39M – 554
2018
Q3 		$1.39M Buy
285,716
+51,744
+22% +$293K 0.16% 187
2018
Q2 		$1.46M Buy
233,972
+210
+0.1% +$1.57K 0.18% 169
2018
Q1 		$1.94M Sell
233,762
-12,761
-5% -$122K 0.26% 117
2017
Q4 		$2.52M Buy
246,523
+8,371
+4% +$80.3K 0.33% 87
2017
Q3 		$2.18M Buy
238,152
+46,423
+24% +$353K 0.3% 102
2017
Q2 		$1.4M Buy
+191,729
New +$1.45M 0.2% 167

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's NEOS Position: Q4 2018 in Review

Essex Investment Management sold out of Neos Therapeutics, Inc (NEOS) in Q4 2018, closing a stake of 285,716 shares — an estimated $1.39M sold.

Essex Investment Management first reported a position in NEOS in Q2 2017 and held it in 6 quarters. The position peaked at $2.52M in Q4 2017. 63 funds tracked by Wall St. Rank hold NEOS as of Q4 2018.

  • Essex Investment Management reported no remaining Neos Therapeutics, Inc position as of Q4 2018 after selling out during the quarter.
  • Essex Investment Management sold 285,716 Neos Therapeutics, Inc shares in Q4 2018, an estimated $1.39M.
  • Essex Investment Management first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 6 quarters.
  • Essex Investment Management's Neos Therapeutics, Inc position peaked at $2.52M in Q4 2017.
  • 63 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.